Fig. 3

The correlation between patient BPRS scores and therapeutic interventions. The data indicate that the BPRS score continued to rise following administration of IVMP and IVIG. However, a significant reduction in the BPRS score was observed after treatment with efgartigimod. Approximately two weeks post-efgartigimod treatment, the patient’s condition recurred, as evidenced by an increase in the BPRS score. Subsequent administration of efgartigimod once again resulted in a decrease in the BPRS score